In the acquisition of companies, clientèle or know-how, non-competition obligations may apply even though they are not expressly agreed
Judgment of the Civil Division of the Supreme Court of 9 May 2016
CAPSULAS Nº 173
Background The judgment in question concerns a claim brought by the purchasers of the shares of a company called Aerlyper, on the basis they understood that the sellers had failed to comply with a non-competition commitment established in the purchase agreement concerning said shares. Specifically, the purchasers claimed that the sellers failed to comply with... Read More
Hablamos de… Riesgo compartido
EL GLOBAL
Hace dos semanas participé en el IV Encuentro sobre Gestión en Farmacia Hospitalaria para Directivos, celebrado en la UIMP bajo la dirección compartida de Miguel Ángel Calleja, Jon Iñaki Betolaza y Antoni Gilabert. Las ideas, en cualquier evento donde participan estas personas, fluyen a un ritmo interesante. Además, el formato del encuentro, que incluía dos... Read More
The medicinal product in Courts in the year 2015
Comunicaciones en Propiedad Industrial y Derecho de la Competencia de la Fundación CEFI, número 78, Mayo-Agosto 2016
2015 has been a year full of important judgments in the field of medicinal products. This article aims to explain the most important decisions in order to give the reader a perspective on developments and clarifications that have been incorporated into the regulation of medicinal products through recent case law in Spanish and European courts.... Read More
Si Vueling vendiese medicamentos…
EL GLOBAL
La semana pasada se cumplió el plazo para publicar las transferencias de valor con origen en la industria farmacéutica y destino en las organizaciones y profesionales sanitarios. Comentando el tema con personas ajenas al sector, no pocas se preguntaban si las compañías farmacéuticas no se habrían pasado de frenada. Es una reflexión legítima desde el... Read More
Efectos secundarios del ‘Brexit’: la sede de la EMA
EL GLOBAL
Hace dos semanas, concluí esta columna, dedicada a qué podría suceder en el mundo del medicamento si ganaba la opción del “leave” en el referéndum británico, con estas palabras: “…si gana la opción del leave el impacto en el ámbito del medicamento y del derecho farmacéutico será muy relevante. Depende de ellos, y si deciden... Read More
“Brexit” and medicinal products
Some relevant issues in the field of pharmaceutical law after the option to “leave” has won the referendum of 23 of June
CAPSULAS Nº 172
It is Friday June 24th, and while writing this CAPSULAS from London, the first thing that comes to my mind is what I wrote in El Global ten days ago: the most important voting this month of June of 2016 is not the General Election that will take place in Spain on Sunday 26th; but... Read More
Challenging the specifications of a tender does not represent an impediment to participation
Ruling 17/2016 of 11 February 2016, of the Catalan Court of Public Sector Contracts
CAPSULAS Nº 171
Background The ruling of the Catalan Court of Public Sector Contracts addressed below was issued as part of a special appeal on contracting brought against the specifications of a tender procedure that sought to award a contract for the supply of medicinal products. The appeal brought challenged, amongst other aspects, a very common clause in... Read More
Supreme Court backs the investigatory powers of the Competition Authority
The Judgement of 6 April 2016 supports the fact that a casual discovery in an inspection serves as grounds to open new disciplinary proceedings
CAPSULAS Nº171
Background This case has its origin in an inspection that the Spanish Competition Authority (CNMC) performed at the offices of Montesa Honda to investigate whether the company had exchanged information and coordinated strategies with its distributors. Following the inspection, the CNMC filed proceedings against Montesa Honda. A couple of months later, the CNMC opened new proceedings alleging... Read More
The Internet can be a sales channel for dermo-cosmetics, but manufacturers may impose certain conditions
Judgement of the Supreme Court of 22 April 2016
CAPSULAS Nº 171
Selective distribution and competition Selective distribution is an option chosen by many manufacturers to market their products. A few years ago, several companies chose this system to place their products in pharmacies; as a result, companies faced significant criticism for restricting the sale of their products to the pharmaceutical channel. Currently, the outlook is quite... Read More
Almost ten years debating hospital dispensing
Judgement of the Supreme Court of 2 March 2016 on the hospital dispensing of medicinal products for non-hospital treatment
CAPSULAS Nº 171
Background The Judgement in question dates back to a ruling issued by the Andalusian Health System (SAS), at the end of 2010, which provided that certain medicinal products should be dispensed via hospital pharmacy services given the need to exercise specific oversight, supervision and control measures, preventing them from being dispensed at pharmacies. The Business... Read More